Improvements seen in physical and mental health, but survivors still have more symptoms than controls at two years
Largest increases seen among non-Hispanic Black males aged 10 to 44 years and in American Indian, Alaska Native males aged 25 to 44 years
Survey of 126 clinicians helps pinpoint barriers to obtaining waivers, prescribing buprenorphine
When probability of suicide attempt increases, gun owners may be less likely to endorse survey items about passive, active suicidal ideation
Low-burden, point-of-care program may increase access to and impact of treatment to assist tobacco cessation
Maternal use of SSRIs, SNRIs in first trimester of pregnancy not linked to increased risk for neonatal seizures or childhood epilepsy in offspring
Yet, study shows buprenorphine is effective in protecting against overdose in this population
States with greater increases in symptoms had fewer deaths from COVID-19 and lower women's unemployment rates
Depression, functional impairment, alcohol use problems, and lower family support ups risk
Risk factors differ based on sex and race and ethnicity